Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
about
Fiducial markers and spacers in prostate radiotherapy: current applicationsPhase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeksQuantitative evaluation of cone-beam computed tomography in target volume definition for offline image-guided radiation therapy of prostate cancer.Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelDosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis.Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysisA method for generating large datasets of organ geometries for radiotherapy treatment planning studies.Radiation dose-volume effects in radiation-induced rectal injury.Adaptive radiotherapy strategies for pelvic tumors - a systematic review of clinical implementations.Urinary adverse effects of pelvic radiotherapy.Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre.Dosimetric impact of different bladder and rectum filling during prostate cancer radiotherapyProstate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications.Adaptive radiation therapy for prostate cancer.Gastrointestinal toxicity associated to radiation therapy."Pelvic radiation disease": new understanding and new solutions for a new disease in the era of cancer survivorship.Reducing rectal injury during external beam radiotherapy for prostate cancer.The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques.Hypofractionated radiotherapy for prostate cancer.Dosimetric impact in the dose-volume histograms of rectal and vesical wall contouring in prostate cancer IMRT treatments.Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy.Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancerAcute toxicity in prostate cancer patients treated with and without image-guided radiotherapy.Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancerReducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives.Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity.Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.Adaptive planning using megavoltage fan-beam CT for radiation therapy with testicular shielding.A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy.Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer.Increased rectal wall stiffness after prostate radiotherapy: relation with fecal urgency.Automatic CT simulation optimization for radiation therapy: A general strategy.Hydrogel spacers in prostate radiotherapy: a promising approach to decrease rectal toxicity.Feasibility of and rectal dosimetry improvement with the use of SpaceOAR® hydrogel for dose-escalated prostate cancer radiotherapy.Dosimetric assessment of prostate cancer patients through principal component analysis (PCA).Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use.Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
P2860
Q26828469-62CC430B-69B8-4F89-A124-29EA0DC722BAQ33613649-4CD04C3E-B5A1-415B-BD36-272AB948D7C7Q33624666-777EF2DE-FA79-4A43-9E6C-94B2D9876F1FQ34161145-9D4B2DBF-76B7-4E97-A187-A7721E78C4AFQ34238364-2B3EDDAD-F764-4A24-A957-418E2B62D9DDQ34487033-77EA9422-1C62-4FFC-BA07-D6B12FD88B72Q34500966-62FBD824-D856-4DF1-AE25-5A11DE32E29DQ34503919-EF3DF1AF-FD6F-4488-BA47-3ACB42CD0E1DQ35870610-930587C4-90FD-4D8C-97A8-7A43C8C34520Q35982957-194F5C85-1C40-4C77-A192-C9CB293A9223Q36450629-8D84BA5F-A524-4DE1-A459-E05B3D887044Q37137423-C8B09F23-F319-412F-94DF-16654A1CA1A5Q37144836-55F95A3A-5E4F-4B04-B68D-695A6416F9A1Q37380104-1769EC65-5F9E-4DF3-92C8-1DCA0A3B3D47Q37706798-8E2D119D-3B04-47E4-B886-9BD56BB304AAQ37780019-863FB7D7-9E1F-472E-9C02-67B065BE6A55Q37824328-38585E87-965D-4452-B239-974B625E36C0Q38106626-23D3CF0B-2532-4A58-9432-66E62393BEBCQ38266168-CDCFCBB8-6C78-4180-8346-686764E4B61BQ38283897-183EAC84-C9C4-4D15-92A8-F490AB1F4E4FQ38810088-54B26081-F22C-4957-9C19-F62EC5AB13ADQ38977242-2E5A29B0-6C08-472F-96B1-9ADBEA231BA8Q38981805-416BC7E6-7B7D-4CAB-A419-9237BA82F0D5Q39135519-813FCFE6-B5C7-4DA7-B8EE-306EBE068A4AQ40959922-DCE70F81-57D0-4545-B587-83C8E96EE533Q41276603-99F6E83E-E94A-4DD4-86DC-A6B80F4A56E7Q41541961-79DA42AA-77DF-4A17-A818-B6F3E1F1D2C2Q41897302-11F66036-7A94-4C0F-9C30-93E58924BFF5Q41981580-5BA2E208-42A8-4F99-BAF1-7AF52EC3945DQ42027688-4A5910F9-54C1-416C-948B-D873693D82D0Q42116748-2171489E-B843-4A19-93EE-AE86821BCB61Q42282596-EBB7FBBB-B273-430A-BC4F-E0E277642C06Q42537131-84B6F013-A5DB-4BA3-963B-309AF68758CAQ43339044-8B9F9EAB-2690-4023-82EA-41333DAF00E1Q46850619-FC712A1D-9FFB-4EC2-A8A3-18AA390E3B98Q47821798-F1DFCBC8-3297-4198-8987-59750FC89297Q47905717-D141349F-2CA5-4CC9-8DC5-8068082A3660Q50485231-9BC625BF-8F4B-404F-9826-FA479D7696F6Q51826236-AC986F39-1F62-4240-B783-A3A44CCE432CQ52958760-D03A1635-644D-4408-9E9B-8424DC14E9CB
P2860
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Dose-volume analysis of predic ...... ive image-guided radiotherapy.
@ast
Dose-volume analysis of predic ...... ive image-guided radiotherapy.
@en
type
label
Dose-volume analysis of predic ...... ive image-guided radiotherapy.
@ast
Dose-volume analysis of predic ...... ive image-guided radiotherapy.
@en
prefLabel
Dose-volume analysis of predic ...... ive image-guided radiotherapy.
@ast
Dose-volume analysis of predic ...... ive image-guided radiotherapy.
@en
P2093
P1476
Dose-volume analysis of predic ...... ive image-guided radiotherapy.
@en
P2093
Alvaro Martinez
Carlos Vargas
David M Lockman
Donald S Brabbins
Frank A Vicini
Gary S Gustafson
Jian Liang
John W Wong
Larry L Kestin
P304
P356
10.1016/J.IJROBP.2004.12.052
P407
P577
2005-08-01T00:00:00Z